Log In
BCIQ
Print this Print this
 

SR-Exendin

  Manage Alerts
Collapse Summary General Information
Company LG Life Sciences Ltd.
DescriptionSustained release exendin
Molecular Target Glucagon-like peptide-1 receptor (GLP-1R) (GLP1R)
Mechanism of ActionGlucagon-like peptide-1 (GLP-1) receptor agonist
Therapeutic ModalityBiologic
Latest Stage of DevelopmentDiscovery
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today